Tiazesim
![]() | |
Clinical data | |
---|---|
Routes of administration | Oral |
ATC code | None |
Legal status | |
Legal status |
|
Identifiers | |
| |
Synonyms | SQ-10,496 |
CAS Number |
5845-26-1 3122-01-8 (hydrochloride) |
PubChem (CID) | 22107 |
ChemSpider |
20775 ![]() |
UNII |
44G76ZB85O ![]() |
KEGG |
D02699 ![]() |
ChEMBL |
CHEMBL2111123 ![]() |
Chemical and physical data | |
Formula | C19H22N2OS |
Molar mass | 326.456 g/mol |
3D model (Jmol) | Interactive image |
| |
|
Tiazesim (INN; brand name Altinil), also known as thiazesim (BAN, USAN) or thiazenone, is a heterocyclic antidepressant related to the tricyclics which, first introduced in 1966 by Squibb Corporation (now Bristol-Myers Squibb), has since been discontinued and is no longer marketed.[1][2]
See also
References
- ↑ C. R Ganellin; D. J Triggle; F.. Macdonald (1997). Dictionary of pharmacological agents. CRC Press. p. 1973. ISBN 978-0-412-46630-4. Retrieved 29 November 2011.
- ↑ The United States patents quarterly. 1969. Retrieved 1 May 2012.
This article is issued from Wikipedia - version of the 4/2/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.